2-113217489-T-G
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_003466.4(PAX8):c.*1044A>C variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.245 in 229,214 control chromosomes in the GnomAD database, including 8,098 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.27 ( 6369 hom., cov: 33)
Exomes 𝑓: 0.20 ( 1729 hom. )
Consequence
PAX8
NM_003466.4 3_prime_UTR
NM_003466.4 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.432
Genes affected
PAX8 (HGNC:8622): (paired box 8) This gene encodes a member of the paired box (PAX) family of transcription factors. Members of this gene family typically encode proteins that contain a paired box domain, an octapeptide, and a paired-type homeodomain. This nuclear protein is involved in thyroid follicular cell development and expression of thyroid-specific genes. Mutations in this gene have been associated with thyroid dysgenesis, thyroid follicular carcinomas and atypical follicular thyroid adenomas. Alternatively spliced transcript variants encoding different isoforms have been described. [provided by RefSeq, Mar 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.66).
BP6
Variant 2-113217489-T-G is Benign according to our data. Variant chr2-113217489-T-G is described in ClinVar as [Benign]. Clinvar id is 330868.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.432 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PAX8 | NM_003466.4 | c.*1044A>C | 3_prime_UTR_variant | 12/12 | ENST00000429538.8 | NP_003457.1 | ||
PAX8 | NM_013952.4 | c.*1121A>C | 3_prime_UTR_variant | 12/12 | NP_039246.1 | |||
PAX8 | NM_013953.4 | c.*1121A>C | 3_prime_UTR_variant | 10/10 | NP_039247.1 | |||
PAX8 | NM_013992.4 | c.*1121A>C | 3_prime_UTR_variant | 9/9 | NP_054698.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PAX8 | ENST00000429538 | c.*1044A>C | 3_prime_UTR_variant | 12/12 | 1 | NM_003466.4 | ENSP00000395498.3 |
Frequencies
GnomAD3 genomes AF: 0.270 AC: 40913AN: 151668Hom.: 6358 Cov.: 33
GnomAD3 genomes
AF:
AC:
40913
AN:
151668
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.196 AC: 15141AN: 77430Hom.: 1729 Cov.: 0 AF XY: 0.197 AC XY: 7070AN XY: 35832
GnomAD4 exome
AF:
AC:
15141
AN:
77430
Hom.:
Cov.:
0
AF XY:
AC XY:
7070
AN XY:
35832
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.270 AC: 40965AN: 151784Hom.: 6369 Cov.: 33 AF XY: 0.267 AC XY: 19776AN XY: 74178
GnomAD4 genome
AF:
AC:
40965
AN:
151784
Hom.:
Cov.:
33
AF XY:
AC XY:
19776
AN XY:
74178
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
569
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Hypothyroidism, congenital, nongoitrous, 2 Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 12, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at